Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$7,498,972
+$455,923 QoQ
Shares Held
29,527
+2.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.96%
of 13F equity value
Holder Rank
#1,294
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New England Research & Management, Inc. holds $31,997,185 across 8 Drug Manufacturers - General names. JNJ ranks #1 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
29,527 | $7,498,972 | |
| 2 | ABBV |
AbbVie Inc.
|
24,774 | $6,234,129 | |
| 3 | AMGN |
Amgen Inc
|
11,880 | $4,301,985 | |
| 4 | LLY |
ELI LILLY & Co
|
3,556 | $4,265,173 | |
| 5 | MRK |
Merck & Co., Inc.
|
27,279 | $3,505,351 | |
| 6 | AZN |
Astrazeneca PLC
|
15,893 | $3,013,630 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
21,070 | $2,661,983 | |
| 8 | PFE |
Pfizer Inc
|
21,427 | $515,962 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,498,972 | 29,527 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $7,043,049 | 28,813 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $6,049,769 | 29,233 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $5,449,122 | 29,388 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $4,546,298 | 29,763 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $4,933,408 | 29,748 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $3,998,887 | 27,651 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,586,460 | 28,301 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $4,174,621 | 28,562 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $4,717,542 | 29,822 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $4,685,428 | 29,893 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,723,586 | 30,328 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $5,067,063 | 30,613 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $4,733,390 | 30,538 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $5,148,464 | 29,145 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $4,824,347 | 29,532 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $4,838,390 | 27,257 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $4,615,423 | 26,042 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $4,251,431 | 24,852 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $4,085,142 | 25,295 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $4,167,098 | 25,295 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $4,157,233 | 25,295 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $5,507,827 | 34,997 | Shares | Sole | 2021-01-07 | |
| 2020-09-30 | $5,262,163 | 35,345 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $4,906,440 | 34,889 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $4,574,994 | 34,889 | Shares | Sole | 2020-06-15 | |
| No filing history on record for this holder in this stock. | ||||||